Fastin | Fastin Weight loss pill Netnutri.com

West New York, New Jersey (Nasdaq) 12 December 2007

Netnutri.com announced the release of Fastin? ¢, a weight loss pill Hi-Tech Pharmaceuticals, which is expected to be among the top aid scheme for the sale in 2008.

Hi-Tech Pharmaceuticals has recently â the commercial rights to Fastin? ¢ Smith Kline Beecham Pharmaceuticals, which had already been built (phentermine HCL) under the brand name Fastin at p ??¢.

Fastin is a pharmaceutical dietary supplement for weight loss in obese specified. Fastin â? ¢ has been delayed two profiles of immediate release and suppression of appetite, energy and weight loss. Fastin’s patent-pending formula contains (ß-methyl-phenethylamine) 37.5mg and was developed with the help of Mark Wright, MD, a bariatric physician.

The National Center for Health Statistics Reports 1962-2000, the number of overweight Americans has increased 13% to an alarming 31% of the population.

-63% of Americans are overweight with a body mass index (BMI) greater than 5.0.

31% are obese with a BMI greater than 30.0.

-childhood obesity in the United States more than tripled in the last two decades.

According to the report of the Surgeon General of the United States, obesity is responsible for 300,000 deaths annually.

For further information on Fastin weight loss or other assistance from netnutri.com http://www.netnutri.com visit us at

Fastin â? ™ is available at http://www.netnutri.com be ordered online or directly by phone 877-807-2007.


>

clear = “all”
FASTIN